Also listed on IMEC, an earlier holder on the record. The recorded assignments below show how it moved.
Term ends May 4, 2036 · High confidence
20-year base term ends May 4, 2036
Held by Katholieke Universiteit Leuven
Filed Nov 6, 2017 as application 15/571,930 · Granted Jun 30, 2020
Base term, 20 years from filing
Today
2016
2036
Clock starts
May 4, 2016
May 4, 2016
Term ends
May 4, 2036
May 4, 2036
Granted
Jun 30, 2020
Jun 30, 2020
base term
fee events
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
6
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. 1 of 3 maintenance fees is paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts May 4, 2016, when application PCT/EP2016/059975, the earliest non-provisional in its chain, was filed (this one was filed Nov 6, 2017) | May 4, 2036 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | May 4, 2036 | High confidence |
This family
| US 10,696,632 | this patent May 2036 | May 2036 |
| US 10,919,854 | In force May 2036 | May 2036 |
| US 11,827,602 | In force no later than Dec 2036 | no later than Dec 2036 |
| US 12,172,959 | In force no later than May 2036 | no later than May 2036 |
| Application 18/987,392 | Pending not computed | not computed |
5 of 6 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jan 16, 2018 Reel 44632, frame 252 | Kesteleyn, Bart Rudolf Romanie; Jonckers, Tim Hugo Maria; Raboisson, Pierre Jean-marie Bernard | Janssen Infectious Diseases Bvba | Assignment of Assignor's Interest |
| Jan 16, 2018 Reel 44632, frame 283 | Bonfanti, Jean-francois | Janssen-Cilag | Assignment of Assignor's Interest |
| Jan 16, 2018 Reel 44632, frame 293 | Bardiot, Dorothee Alice Marie-eve; Marchand, Arnaud Didier M. | Cistim Leuven VZW | Assignment of Assignor's Interest |
| Jan 16, 2018 Reel 44632, frame 324 | Cistim Leuven VZW | Katholieke Universiteit Leuven | Assignment of Assignor's Interest |
| Jan 16, 2018 Reel 44632, frame 344 | Janssen-Cilag | Janssen Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
| Jan 16, 2018 Reel 44632, frame 355 | Janssen Infectious Diseases Bvba | Janssen Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
| Apr 27, 2020 Reel 52501, frame 369 | Kesteleyn, Bart Rudolf Romanie | Janssen Pharmaceutica N.V. | Assignment of Assignor's Interest |
| Apr 27, 2020 Reel 52501, frame 429 | Bonfanti, Jean-François | Janssen-Cilag | Assignment of Assignor's Interest |
| Apr 27, 2020 Reel 52501, frame 486 | Jonckers, Tim Hugo Maria | Janssen Pharmaceutica N.V. | Assignment of Assignor's Interest |
| Apr 27, 2020 Reel 52501, frame 510 | Raboisson, Pierre Jean-marie Bernard | Janssen Pharmaceutica N.V. | Assignment of Assignor's Interest |
| Apr 27, 2020 Reel 52501, frame 566 | Bardiot, Dorothée Alice Marie-Eve | Cistim Leuven VZW | Assignment of Assignor's Interest |
| Apr 27, 2020 Reel 52501, frame 627 | Marchand, Arnaud Didier M | Cistim Leuven VZW | Assignment of Assignor's Interest |
| Apr 27, 2020 Reel 52501, frame 658 | Janssen Pharmaceutica N.V. | Janssen Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
| Apr 27, 2020 Reel 52501, frame 732 | Janssen-Cilag | Janssen Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
| May 4, 2020 Reel 52561, frame 818 | Cistim Leuven VZW | Katholieke Universiteit Leuven | Assignment of Assignor's Interest |
| May 12, 2020 Reel 52640, frame 431 | Janssen Infectious Diseases Bvba | Janssen Pharmaceutica N.V. | Change of Name |
| Jul 7, 2026 Reel 75932, frame 967 | Janssen Pharmaceuticals, Inc. | Katholieke Universiteit Leuven | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
May 2036
Term ends May 4, 2036. Maintenance fees still fall due before then
Citations
22
later US patents cite this one
That is top 10% of utility patents granted in 2020 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.